News
Exactly one week from today the call for the Venture Challenge Fall 2022 will close!
Does your team tick all the boxes to join the Venture Challenge?
Sirius Medical is pleased to announce the first two US hospitals to implement Pintuition
Venture Challenge alumnus Sirius Medical is pleased to announce that Ascens
Deadline for Venture Challenge fall 2022 is approaching!
Not sure whether to apply? Please read what Praneeta Konduri, participant of the previous Venture Challenge has to say:
The Winner of the Venture Challenge Fall 2021 is QurieGen!
Due to Covid, last year’s winners of the Venture Challenge were announced today at the Dutch Life Sciences Conference. The proud winner of the fall edition is QurieGen, formerly known as Monoceros Analytics. The innovative startup QurieGen has developed a single-cell sequencing-based method to map the changes in transcriptome, membrane and 100’ of intracellular (phospho)proteins simultaneously across multiple pathways (IP filed) to obtain a high-resolution map of cellular response.
The Winner of the Venture Challenge Summer 2021 is Sella Therapies!
Due to Covid, last year’s winners of the Venture Challenge were announced today at the Dutch Life Sciences Conference. The proud winner of the 2021 summer edition is Sella Therapies. The innovative startup Sella Therapies has developed a novel therapy for chronic pain relief that targets the body’s internal neuropeptide system.
Apply for Venture Challenge fall 2022 edition!
Are you still in doubt whether to apply for the venture challenge fall 2022 edition? Perhaps the winner of the last Venture Challenge can pursuade you!
‘It’s fantastic to make a discovery, but even cooler if we can really help patients’
From a scientific idea to a multi-million euro investment: the successes of the many NWO Venture Challenge alumni reveal what can be achieved if you take science out of the lab onto the market.
Venture Challenge Fall 2022 Now open for applications!
The proven Venture Challenge coaching programme focuses on developing your initial idea into a solid business case with boot camps, 1-on-1 coaching and mentoring.
Meet the teams of the Venture Challenge Spring 2022
Last week five teams started their Venture Challenge adventure. In the first three-day workshop the highly motivated teams worked on their customer value proposition, long-term vision and competitive positioning.
Quell Therapeutics and Cellistic™ enter a strategic collaboration
After Ncardia launched its affiliate company Cellistic last week, dedicated to making large-scale allogeneic cell therapy production a reality, they are proud to now enter a strategic collaboration with Quell Therapeutics, to develop an iPSC-derived allogeneic T-regulatory cell therapy platform.